학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 67건 | 목록 1~20
Academic Journal
Witjes VM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; de Hullu JA; Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands.; van Remortele A; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Vreede L; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Rosenberg EH; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Cillessen SAGM; Department of Pathology, Amsterdam University Medical Center, Amsterdam, the Netherlands.; Groenendijk FH; Department of Pathology and Clinical Bioinformatics, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Steeghs EMP; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.; Moonen L; Department of Pathology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands.; Mensenkamp AR; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.; Ter Elst A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Hoogerbrugge N; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Ligtenberg MJL; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands. Marjolijn.Ligtenberg@radboudumc.nl.; Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands. Marjolijn.Ligtenberg@radboudumc.nl.; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands. Marjolijn.Ligtenberg@radboudumc.nl.
Publisher: Springer International Country of Publication: Germany NLM ID: 9423843 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2307 (Electronic) Linking ISSN: 09456317 NLM ISO Abbreviation: Virchows Arch Subsets: MEDLINE
Academic Journal
Froyen G; Laboratory for Molecular Diagnostics, Department of Clinical Biology, Jessa Hospital, Hasselt, Belgium.; Faculty of Medicine and Life Sciences, University of Hasselt, Belgium.; Department Jessa & Science, LCRC (-MHU), Hasselt, Belgium.; Volders PJ; Laboratory for Molecular Diagnostics, Department of Clinical Biology, Jessa Hospital, Hasselt, Belgium.; Department Jessa & Science, LCRC (-MHU), Hasselt, Belgium.; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Geerdens E; Laboratory for Molecular Diagnostics, Department of Clinical Biology, Jessa Hospital, Hasselt, Belgium.; Berden S; Laboratory for Molecular Diagnostics, Department of Clinical Biology, Jessa Hospital, Hasselt, Belgium.; Van der Meulen J; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Molecular Diagnostics Ghent University Hospital (MDG), Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.; De Cock A; Molecular Diagnostics Ghent University Hospital (MDG), Ghent University Hospital, Ghent, Belgium.; Vermeire S; Department of Pathology, AZ Sint-Jan Brugge AV, Bruges, Belgium.; Van Huysse J; Department of Pathology, AZ Sint-Jan Brugge AV, Bruges, Belgium.; de Barsy M; Institute of Pathology and Genetics (IPG), Gosselies, Belgium.; Beniuga G; Institute of Pathology and Genetics (IPG), Gosselies, Belgium.; de Leng WWJ; Department of Pathology, University Medical Centre Utrecht, The Netherlands.; Jansen AML; Department of Pathology, University Medical Centre Utrecht, The Netherlands.; Demers I; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands.; Ozgur Z; Genomics Core Facility, Erasmus University Medical Center, Rotterdam, The Netherlands.; Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Speel EM; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands.; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; van IJcken WFJ; Genomics Core Facility, Erasmus University Medical Center, Rotterdam, The Netherlands.; Maes B; Laboratory for Molecular Diagnostics, Department of Clinical Biology, Jessa Hospital, Hasselt, Belgium.; Faculty of Medicine and Life Sciences, University of Hasselt, Belgium.; Department Jessa & Science, LCRC (-MHU), Hasselt, Belgium.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Academic Journal
Plugge SF; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands.; Ma H; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; van der Vaart JY; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands.; Sprangers J; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands.; Morsink FHM; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Xanthakis D; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands.; Jamieson C; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands.; Stroot KBW; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands.; Keijzer AR; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands.; Margaritis T; Princess Maxima Center for Pediatric Oncology, Utrecht, Utrecht, the Netherlands.; Candelli T; Princess Maxima Center for Pediatric Oncology, Utrecht, Utrecht, the Netherlands.; Straver R; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands.; de Ridder J; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands.; Holstege FCP; Princess Maxima Center for Pediatric Oncology, Utrecht, Utrecht, the Netherlands; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Offerhaus GJA; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Merenda A; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: a.merenda@huborganoids.nl.; Maurice MM; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: m.m.maurice@umcutrecht.nl.
Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0012 (Electronic) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE
Academic Journal
Bruinsma RS; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Fiocco MF; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Biomedical data Science, Section Medical Statistics, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.; Mathematical Institute, Leiden University, 2300 RA Leiden, The Netherlands.; Dierselhuis MP; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Langenberg KP; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Molenaar JJ; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Kester LA; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; van Noesel MM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Division Imaging & Cancer, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Tytgat GAM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; van de Ven CP; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; de Krijger RR; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Steeg AFWV; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Vallentgoed WR; Neurology Department Erasmus MC, Rotterdam, The Netherlands. w.r.vallentgoed@amsterdamumc.nl.; Hoogstrate Y; Neurology Department Erasmus MC, Rotterdam, The Netherlands.; van Garderen KA; Radiology Department Erasmus MC, Rotterdam, The Netherlands.; van Hijfte L; Neurology Department Erasmus MC, Rotterdam, The Netherlands.; van Dijk E; Pathology Department AUMC, Amsterdam, The Netherlands.; Kouwenhoven MCM; Neurology Department AUMC, Amsterdam, The Netherlands.; Niers JM; Neurology Department AUMC, Amsterdam, The Netherlands.; Draaisma K; Neurology and Neurosurgery Department UMCU, Utrecht, The Netherlands.; Martin I; Epidemiology and Biostatistics Department AUMC, Amsterdam, The Netherlands.; de Leng WWJ; Pathology Department UMCU, Utrecht, The Netherlands.; Tesileanu CMS; Neurology Department Erasmus MC, Rotterdam, The Netherlands.; de Heer I; Neurology Department Erasmus MC, Rotterdam, The Netherlands.; Diepeveen M; Neurology Department Erasmus MC, Rotterdam, The Netherlands.; Lavrova A; Radiology Department Erasmus MC, Rotterdam, The Netherlands.; Eijk PP; Pathology Department AUMC, Amsterdam, The Netherlands.; Bühler M; Neurology Department University Hospital and University of Zurich, Zurich, Switzerland.; Wick W; Department of Neurology and Neuro-oncology Program, Heidelberg University Hospital, Heidelberg, Germany.; Clement PM; Department of Oncology, KU Leuven, Leuven, Belgium.; Sanson M; Hôpitaux Universitaires La Pitié Salpêtrière, Paris, France.; Franceschi E; IRCCS Istituto Scienze Neurologiche di Bologna, Nervous System Medical Oncology Department, Bologna, Italy.; Gorlia T; EORTC Headquarters, Brussels, Belgium.; Golfinopoulos V; EORTC Headquarters, Brussels, Belgium.; Weller M; Neurology Department University Hospital and University of Zurich, Zurich, Switzerland.; Weiss T; Neurology Department University Hospital and University of Zurich, Zurich, Switzerland.; Robe PA; Neurology and Neurosurgery Department UMCU, Utrecht, The Netherlands.; Kros JM; Pathology Department Erasmus MC, Rotterdam, The Netherlands.; Smits M; Radiology Department Erasmus MC, Rotterdam, The Netherlands.; van de Wiel M; Epidemiology and Biostatistics Department AUMC, Amsterdam, The Netherlands.; Ylstra B; Pathology Department AUMC, Amsterdam, The Netherlands.; Verhaak RGW; Neurosurgery Department AUMC, Amsterdam, The Netherlands.; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.; van den Bent MJ; Neurology Department Erasmus MC, Rotterdam, The Netherlands.; Westerman BA; Pathology Department AUMC, Amsterdam, The Netherlands.; Wesseling P; Pathology Department AUMC, Amsterdam, The Netherlands. p.wesseling@amsterdamumc.nl.; French PJ; Neurology Department Erasmus MC, Rotterdam, The Netherlands. p.french@erasmusmc.nl.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Academic Journal
Franken IA; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.; Ketelaars SLC; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Rubio-Alarcón C; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Delis-van Diemen P; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Spaapen TOM; Laboratory of Translational Oncology, University Medical Centre Utrecht, Utrecht, the Netherlands.; Heilijgers F; Department of Surgery, Leiden University Medical Centre, the Netherlands.; da Silva Guimaraes M; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; van Nassau SCMW; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.; Schraa SJ; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.; Mesker WE; Department of Surgery, Leiden University Medical Centre, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Centre Utrecht, Utrecht, the Netherlands.; Kranenburg O; Laboratory of Translational Oncology, University Medical Centre Utrecht, Utrecht, the Netherlands.; Meijer GA; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Koopman M; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.; Sausen M; Labcorp Oncology, Baltimore, MD, USA.; Vink GR; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.; Abeln S; Department of Information and Computing Sciences, Department of Biology, Utrecht University, Utrecht, the Netherlands.; Fijneman RJA; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roodhart JML; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: j.roodhart@umcutrecht.nl.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Verkerk K; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Haj Mohammad SF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Verbeek FAJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Timmer H; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; van Maren MA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Parra-Martinez M; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; Marchetti S; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Monkhorst K; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Smabers LP; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Division of Imaging and Cancer, Laboratory of Translational Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.; Nienhuis HH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; Ciftcibasi IÖA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Wensink GE; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Huismans MA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Valkenburg-van Iersel LBJ; Department of Internal Medicine, Division of Medical Oncology, GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.; Cirkel GA; Department of Medical Oncology, Meander Medical Center, Amersfoort, the Netherlands.; Gootjes EC; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Verheul HMW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Jeurissen FJ; Department of Internal Medicine, Haaglanden Medical Center, The Hague, Netherlands.; Bol GM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.; Kranenburg O; Division of Imaging and Cancer, Laboratory of Translational Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.; Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Cuppen E; Hartwig Medical Foundation, Amsterdam, the Netherlands.; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. j.roodhart@umcutrecht.nl.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
Academic Journal
Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.; Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Zeverijn LJ; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Geurts BS; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verkerk K; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Haj Mohammad SF; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands.; van de Luijtgaarden ACM; Department of Medical Oncology, Reinier de Graaf Hospital, Delft, the Netherlands.; van Voorthuizen T; Department of Medical Oncology, Rijnstate, Arnhem, the Netherlands.; Buffart TE; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center, Amsterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Voest EE; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Editorial & Opinion
Priesterbach-Ackley LP; Department of Pathology, University Medical Center Utrecht, Internal Mail No. H04.312, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands.; Cordier F; Department of Pathology, University Medical Center Utrecht, Internal Mail No. H04.312, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands.; Department of Pathology, Ghent University Hospital, Ghent, Belgium.; de Witt Hamer P; Department of Neurosurgery, Amsterdam University Medical Centers/VUmc and Brain Tumor Center, Amsterdam, The Netherlands.; Snijders TJ; Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, Utrecht, The Netherlands.; Robe PA; Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, Utrecht, The Netherlands.; Küsters B; Department of Pathology, Radboudumc, Nijmegen, The Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Internal Mail No. H04.312, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands.; den Dunnen WFA; Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands.; Brandsma D; Department of Neuro-Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Jansen C; Laboratory for Pathology Eastern Netherlands, LABPON, Hengelo, The Netherlands.; Wesseling P; Department of Pathology, Amsterdam University Medical Centers/VUmc and Brain Tumor Center Amsterdam, and Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Muhlebner A; Department of Pathology, University Medical Center Utrecht, Internal Mail No. H04.312, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands. a.muhlebner@umcutrecht.nl.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE
Academic Journal
Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.; Geurts BS; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Zeverijn LJ; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; de Wit GF; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands.; Kusters B; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Beerepoot LV; Department of Internal Medicine, ETZ Hospital (Elisabeth-TweeSteden Ziekenhuis), Tilburg, The Netherlands.; de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; de Groot DA; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.; de Groot JWB; Isala Oncology Center, Isala, Zwolle, The Netherlands.; Hoeben A; Division of Medical Oncology, Department of Internal Medicine, GROW School of Oncology and Development Biology, Maastricht University Center+, Maastricht, The Netherlands.; Buter J; Department of Medical Oncology, Amsterdam University Medical Center, Location VuMC, Amsterdam, The Netherlands.; Gelderblom HAJ; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Voest EE; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam,The Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
van Opijnen MP; Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands. m.p.van_opijnen@lumc.nl.; Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands. m.p.van_opijnen@lumc.nl.; Broekman MLD; Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands.; Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands.; Cuppen E; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands.; Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Ter Elst A; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands.; van Eijk R; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Mühlebner A; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; Jansen C; Laboratorium Pathologie Oost-Nederland, Hengelo, The Netherlands.; van der Geize R; Laboratorium Pathologie Oost-Nederland, Hengelo, The Netherlands.; Speel EM; Department of Pathology, GROW-School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands.; Groenen PJTA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; de Vos FYF; Department of Medical Oncology, Utrecht University Medical Center, Utrecht, The Netherlands.; Wesseling P; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; Maas SLN; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE
Academic Journal
van Garderen KA; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Medical Delta, Delft, The Netherlands.; Vallentgoed WR; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Lavrova A; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Niers JM; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; de Leng WWJ; Department of Pathology, UMC Utrecht, Utrecht, The Netherlands.; Hoogstrate Y; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; de Heer I; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Ylstra B; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; van Dijk E; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Klein S; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Draaisma K; Department of Neurosurgery, UMC Utrecht, The Netherlands.; Robe PAJT; Department of Neurosurgery, UMC Utrecht, The Netherlands.; Verhaak RGW; Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.; Department of Neurosurgery, Amsterdam UMC, Amsterdam, The Netherlands.; Westerman BA; Department of Neurosurgery, Amsterdam UMC, Amsterdam, The Netherlands.; French PJ; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; van den Bent MJ; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.; Kouwenhoven MCM; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Kros JM; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.; Wesseling P; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Smits M; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Medical Delta, Delft, The Netherlands.
Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Academic Journal
Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Looze EJ; Division of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Thavaneswaran S; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; van Berge Henegouwen JM; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Simes RJ; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Sjoquist KM; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; van der Wijngaart H; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Sebastian L; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Lee CK; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Espinoza D; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Lin FP; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Leek LVM; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.; Thomas DM; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Academic Journal
Ebbelaar CF; Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands; Department of Pathology, University Medical Centre Utrecht, Utrecht, the Netherlands. Electronic address: c.f.ebbelaar@lumc.nl.; Jansen AML; Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands.; Speet LCM; Department of Pathology, Leiden University Medical Centre, Leiden, the Netherlands; Department of Pathology, Symbiant, Hoorn, the Netherlands.; Schutgens F; Department of Pathology, University Medical Centre Utrecht, Utrecht, the Netherlands.; Zoetemeyer S; Department of Pathology, Reinier de Graaf Gasthuis, Delft, the Netherlands.; Cleton-Jansen AM; Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands.; van Dijk MR; Department of Pathology, University Medical Centre Utrecht, Utrecht, the Netherlands.; Breimer GE; Department of Pathology, University Medical Centre Utrecht, Utrecht, the Netherlands.; Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Centre Utrecht, Utrecht, the Netherlands.; van Doorn R; Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands; Department of Dermatology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Suijkerbuijk KPM; Department of Medical Oncology, Cancer Centre, University Medical Centre Utrecht, Utrecht, Netherlands.; Schrader AMR; Department of Pathology, Leiden University Medical Centre, Leiden, the Netherlands.; Blokx WAM; Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
Academic Journal
Verkerk K; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands.; van de Haar J; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands.; Spiekman AC; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Berge Henegouwen JM; Oncode Institute, Utrecht, The Netherlands; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands.; van der Wijngaart H; Department of Medical Oncology, GROW, Maastricht University Medical Centre, Maastricht, The Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands.; Gelderblom AJ; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands. Electronic address: e.voest@nki.nl.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Academic Journal
Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Battaglia TW; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van Berge Henegouwen JM; Oncode Institute, Utrecht, the Netherlands.; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van der Wijngaart H; Oncode Institute, Utrecht, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centre, location VUMC, Amsterdam, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Centre Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Centre Utrecht, Utrecht, the Netherlands.; Opdam FL; Department of Clinical Pharmacology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; de Jonge MJA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Cirkel GA; Department of Medical Oncology, Meander, Amersfoort, the Netherlands.; Labots M; Department of Medical Oncology, Amsterdam University Medical Centre, location VUMC, Amsterdam, the Netherlands.; Hoeben A; Department of Medical Oncology, Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; Kerver ED; Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.; Bins AD; Department of Medical Oncology, Amsterdam University Medical Centre, location AUMC, Amsterdam, the Netherlands.; Erdkamp FGL; Department of Medical Oncology, Zuyderland Hospital, Sittard-Geelen, the Netherlands.; van Rooijen JM; Department of Medical Oncology, Martini Hospital, Groningen, the Netherlands.; Houtsma D; Department of Medical Oncology, Haga Hospital, The Hague, the Netherlands.; Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, the Netherlands.; de Groot JB; Department of Medical Oncology, Isala, Zwolle, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands. e.voest@nki.nl.; Oncode Institute, Utrecht, the Netherlands. e.voest@nki.nl.
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Academic Journal
Aouam O; Department of Pathology, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands.; Janssen NG; Department of Oral and Maxillofacial Pediatric Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands.; Breimer GE; Department of Pathology, University Medical Center Utrecht, Utrecht, 3584 CX, The Netherlands. g.e.breimer-2@umcutrecht.nl.
Publisher: Springer Science+ Business Media Country of Publication: United States NLM ID: 101304010 Publication Model: Electronic Cited Medium: Internet ISSN: 1936-0568 (Electronic) Linking ISSN: 1936055X NLM ISO Abbreviation: Head Neck Pathol Subsets: MEDLINE
Academic Journal
Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Battaglia TW; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van Berge Henegouwen JM; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands.; de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van der Wijngaart H; Department of Medical Oncology, Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.; Chalabi M; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Devriese LA; Division Beeld & Oncologie, Department of Medical Oncology, Utrecht University Medical Center, Utrecht, the Netherlands.; Erdkamp FLG; Department of Medical Oncology, Zuyderland Hospital, Sittard-Geleen, the Netherlands.; Labots M; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.; de Jonge MJA; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Kerver ED; Department of Medical Oncology, OLVG, Amsterdam, the Netherlands.; Bins AD; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Leek LVM; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Notohardjo JCL; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Wessels LFA; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; van de Haar J; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, the Netherlands.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] de Leng WWJ
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어